Faron Pharmaceuticals Oy

(LSE) FARN

Current Price$40.00

Market Cap$8.38B

Since IPO (2015)-81%

5 Year-85%

1 Year-79%

1 Month-6%

Faron Pharmaceuticals Oy Financials at a Glance

Market Cap

$8.38B

Revenue (TTM)

$0.00

Net Income (TTM)

$7.87M

EPS (TTM)

$-20.67

P/E Ratio

-2.03

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$40.00

Volume

16,985

Open

$40.45

Price

$40.00

Volume

16,985

Open

$40.45

Previous Close

$40.00

Daily Range

$39.20 - $40.45

52-Week Range

$39.00 - $262.77

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$40.00

Volume

16,985

Open

$40.45

Previous Close

$40.00

Daily Range

$39.20 - $40.45

52-Week Range

$39.00 - $262.77

FARN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Faron Pharmaceuticals Oy

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Juho Markku Jalkanen, PhD, MD

Website

www.faron.com

Headquarters

Turku, 20520, FI

FARN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-46%

Earnings Yield

-49.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.38B

Shares Outstanding

199.51M

Volume

16.98K

Avg. Volume

212.86K

Financials (TTM)

Gross Profit

$325.89K

Operating Income

$20.26M

EBITDA

$19.93M

Operating Cash Flow

$24.34M

Capital Expenditure

$0.00

Free Cash Flow

$24.34M

Cash & ST Invst.

$12.31M

Total Debt

$24.67M

Faron Pharmaceuticals Oy Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$174.94K

N/A

Gross Margin

0.00%

N/A

Market Cap

$8.38B

N/A

Market Cap/Employee

$335.19M

N/A

Employees

N/A

Net Income

$7.83M

-45394.7%

EBITDA

$8.18M

-51888.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$12.36M

-98.2%

Accounts Receivable

$512.83K

N/A

Inventory

$0.00

N/A

Long Term Debt

$14.27M

+50.7%

Short Term Debt

$10.40M

+185.8%

Return on Assets

-45.68%

N/A

Return on Invested Capital

4.91%

N/A

Free Cash Flow

$11.44M

-99658.3%

Operating Cash Flow

$11.44M

-99658.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVCT.LAvacta Group Plc

AVCT.LAvacta Group Plc$73.60-2.52%

PRTC.LPureTech Health plc

PRTC.LPureTech Health plc$130.00+3.83%

BXP.LBeximco Pharmaceuticals Limited

BXP.LBeximco Pharmaceuticals Limited$42.50+0.00%

SCLP.LScancell Holdings plc

SCLP.LScancell Holdings plc$13.75+5.77%

BVXP.LBioventix PLC

BVXP.LBioventix PLC$1650.00-2.94%

4BB.L4basebio PLC

4BB.L4basebio PLC$505.00+0.00%

OBI.LOndine Biomedical Inc.

OBI.LOndine Biomedical Inc.$12.50+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$84.52-0.01%

NOKNokia

NOKNokia$11.30+0.05%

POETPoet Technologies

POETPoet Technologies$8.03+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.74-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.14-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$18.36-0.02%

PFEPfizer

PFEPfizer$26.48-0.01%

Questions About FARN

What is the current price of Faron Pharmaceuticals Oy?

Faron Pharmaceuticals Oy is trading at GBX 40.00 per share.

What is the 52-week range for Faron Pharmaceuticals Oy?

Over the past 52 weeks, Faron Pharmaceuticals Oy has traded between GBX 39.00 and GBX 262.77.

How much debt does Faron Pharmaceuticals Oy have?

As of the most recent reporting period, Faron Pharmaceuticals Oy reported total debt of $21.55M.

How much cash does Faron Pharmaceuticals Oy have on hand?

Faron Pharmaceuticals Oy reported $10.75M in cash and cash equivalents in its most recent financial results.

What is Faron Pharmaceuticals Oy’s dividend yield?

Faron Pharmaceuticals Oy does not currently have a dividend yield.

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy Financials at a Glance

FARN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Faron Pharmaceuticals Oy

FARN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Faron Pharmaceuticals Oy Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FARN

What is the current price of Faron Pharmaceuticals Oy?

What is the 52-week range for Faron Pharmaceuticals Oy?

How much debt does Faron Pharmaceuticals Oy have?

How much cash does Faron Pharmaceuticals Oy have on hand?

What is Faron Pharmaceuticals Oy’s dividend yield?

Premium Investing Services